KELLY HARMON: Open Payments
NPI 1205520772 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 10 payments from 5 companies in 2025. Trend: 2023 $76 · 2024 $180 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $127 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| Calliditas Therapeutics US Inc. | 1 | $35 |
| Optinose US, Inc. | 2 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
Products named: VRAYLAR, DUPIXENT, TARPEYO, Xhance, NEFFY.
Industry payments across LA — which companies pay providers there.
